The Ultimate American Guide to Stem Cell Therapy in Thailand

🔎 Stem Cell Therapy in Thailand for Americans: Quick Overview

Costs also vary dramatically. Based on current provider pricing and real treatment proposals reviewed by STEMCIERGE, treatment can range from around $10,000 for a relatively straightforward orthopedic case to more than $100,000 for complex, intensive regenerative programs.

The key principle: Do not choose a country first and then look for a treatment. Start with your diagnosis, evidence, treatment strategy, physician, and product. The country comes later.

Disclaimer: This article is educational and does not replace individualized medical advice. Treatment suitability should be assessed by a qualified physician who has reviewed your diagnosis, imaging, medical history, and medications.

Thailand's regenerative medicine landscape is also changing. In 2026, the Thai FDA described an expanding Advanced Therapy Medicinal Product (ATMP) system covering clinical use, manufacturing standards, research pathways, and commercialization.¹

That is encouraging from a regulatory-development perspective.

It also makes one distinction particularly important:

“Available in Thailand” and “approved for this exact use” are not the same thing.

🇹🇭 Why Are Americans Considering Stem Cell Therapy in Thailand?

Americans generally consider Thailand because it provides access to regenerative medicine programs that may differ from what they can readily obtain in the United States.

Thailand also has a mature private healthcare and medical-tourism sector. Some regenerative programs combine multiple parts of care under one treatment plan, including:

• physician evaluation;
• imaging and diagnostics;
• cell-based treatment;
• local injections;
• physiotherapy;
• rehabilitation;
• and supportive therapies.

For patients who want to dedicate several days or weeks to treatment and recovery, that can be attractive.

Another reason is treatment availability. Some private providers in Thailand offer expanded mesenchymal stromal/stem cell programs, including umbilical cord-derived MSCs, that are not FDA-approved for common orthopedic, neurological, or wellness indications in the United States.

However, greater availability should not be confused with stronger evidence.

A therapy can be offered commercially and still have substantial uncertainty around its long-term safety, efficacy, or optimal patient selection.

⚖️ Is Stem Cell Therapy Legal and FDA-Approved in Thailand?

Cell therapies are regulated in Thailand, but Americans should verify the regulatory status of the exact treatment they are being offered.

Thailand regulates cell therapy within its broader ATMP framework. The Thai FDA has described oversight involving authorization before human use, manufacturing standards, clinical research, and registration for products intended for commercial distribution.¹

Thailand is also building formal infrastructure around ATMP manufacturing and research, including GMP-aligned academic manufacturing facilities and regulated research pathways.¹

🏛️ Does stem cell therapy in Thailand need U.S. FDA approval?

No.

U.S. FDA approval determines whether a product can be legally marketed for a particular use in the United States. It does not determine whether a treatment can legally be provided in Thailand.

That said, FDA status is still useful information for Americans because it shows whether a particular therapy has undergone formal U.S. review for a defined indication.

The FDA has approved cell-based medicines. For example, Ryoncil became the first FDA-approved mesenchymal stromal cell therapy in 2024 for a very specific pediatric indication: steroid-refractory acute graft-versus-host disease.²

That does not mean MSCs are FDA-approved for knee osteoarthritis, spinal cord injury, anti-aging, or most other regenerative uses marketed internationally.

The FDA continues to warn consumers about unapproved regenerative medicine products marketed for orthopedic, neurological, and other conditions.³

🔍 Ask a better regulatory question

Instead of asking only:

“Is this FDA-approved?”

Ask:

“What Thai regulatory pathway applies to this exact cell product and its use in my treatment?”

Then verify four different things:

Clinic → Physician → Cell product → Indication

These are not interchangeable.

A licensed physician does not automatically prove that a particular cell product is registered for every use.

Likewise, a legitimate cell product does not prove that it works for every condition.

🧬 What Stem Cell Treatments Do Americans Encounter in Thailand?

Americans exploring regenerative medicine in Thailand may encounter several different types of cell-based or related therapies.

These can include:

• umbilical cord-derived MSCs;
• bone marrow-derived approaches;
• adipose-derived cells;
• localized orthopedic injections;
• intravenous MSC administration;
• combined IV and local administration;
• extracellular vesicles or exosomes;
• and treatment packages incorporating PRP, physiotherapy, or rehabilitation.

These therapies should not be treated as interchangeable.

Two clinics may both advertise “100 million stem cells,” yet deliver completely different treatments.

Important variables include:

• cell source;
• donor screening;
• culture method;
• passage;
• viable cell count;
• sterility testing;
• route of administration;
• dose per treatment site;
• timing between manufacturing and administration;
• and the evidence supporting that specific protocol.

Exosomes are another example. They are frequently marketed alongside stem cells but are not themselves stem cells. The FDA states that there are currently no FDA-approved exosome products.³

Cell count is only one piece of the treatment.

More cells do not automatically mean a better product, a better protocol, or a better outcome.

📚 What Does the Scientific Evidence Actually Show?

There is no single body of evidence for “stem cell therapy.”

The evidence needs to be assessed separately for each condition, cell source, preparation, dose, administration route, and patient population.

The International Society for Stem Cell Research emphasizes rigorous evaluation of safety and effectiveness before stem-cell interventions become routine clinical treatments.⁴

A simplified evidence spectrum looks like this:

Treatment areaGeneral evidence positionHematopoietic stem-cell transplantation for selected diseasesEstablished medicineKnee osteoarthritisPromising for some symptom outcomes, but uncertainty remainsOther orthopedic applicationsEmerging and highly indication-specificSpinal cord injuryInvestigationalMany neurological conditionsInvestigationalAutoimmune/systemic applicationsDisease- and protocol-specificAnti-aging and general longevityClinical benefit remains unestablished

One of the most important distinctions for patients is between biological rationale and proven clinical outcome.

A therapy may influence inflammation, growth factors, immune signaling, or laboratory biomarkers.

That does not automatically demonstrate that it restores function, regenerates tissue, prevents surgery, or creates a meaningful long-term improvement.

🦵 What Does the Evidence Say About Stem Cell Therapy for Knee Osteoarthritis?

Knee osteoarthritis is one of the more extensively studied orthopedic applications of stem-cell-based therapy.

A 2025 Cochrane review included 25 randomized trials involving 1,341 participants. Compared with placebo injections, stem-cell injections may provide small improvements in pain and function at around six months.⁵

In the review's primary placebo comparison, pain improved by approximately 1.2 points on a 0–10 scale, while function improved by approximately 14.2 points on a 0–100 scale.⁵

However, the certainty of this evidence was rated low. Studies differed considerably in cell source, preparation, dose, and methodology.

That makes strong promises inappropriate.

🇹🇭 What has research in Thailand found?

Thailand has also produced academic research on regenerative treatment for knee osteoarthritis.

A randomized Thai study involving 48 patients with early-stage knee osteoarthritis compared adipose-derived MSCs with hyaluronic acid. Researchers reported clinical improvement and favorable MRI findings in the MSC group over six months.⁶

The findings are promising.

But the study was relatively small and focused on early-stage disease.

It does not prove that every commercial MSC treatment in Thailand will produce the same results.

🦴 Can stem cells regrow knee cartilage?

Current evidence does not establish that stem-cell injections reliably regenerate clinically meaningful normal cartilage or cure knee osteoarthritis.

This distinction is crucial because patients sometimes hear “my knee feels better” and interpret that as “my cartilage grew back.”

Those are different outcomes.

💡 Symptom improvement ≠ cartilage regeneration

A patient may experience less pain and improved function without rebuilding a normal joint.

Pain, function, MRI changes, cartilage structure, and avoidance of future surgery should be evaluated separately.

Disease severity matters too.

A patient with early degenerative changes is not equivalent to someone with severe deformity, instability, extensive meniscal damage, and end-stage bone-on-bone osteoarthritis.

That is why imaging and proper orthopedic evaluation matter before discussing the number of stem cells.

🧠 What About Stem Cells for Spinal Cord Injury and Neurological Conditions?

Stem-cell treatment for serious spinal cord injuries and many neurological conditions remains investigational.

These are also conditions where patient selection becomes far more complex.

Important factors can include:

• injury level;
• completeness of injury;
• remaining motor and sensory function;
• imaging;
• time since injury;
• spasticity;
• bowel and bladder function;
• respiratory complications;
• rehabilitation potential;
• and overall medical stability.

STEMCIERGE has seen how differently providers can approach the same complex patient.

In one anonymous American spinal cord injury case, two Thai providers proposed fundamentally different strategies.

One evaluation centered on epidural spinal cord stimulation.

Another proposed an intensive month-long regenerative medicine program involving repeated stem-cell administration.

The lesson was not that one program was automatically better.

It was this:

Complex neurological patients need a clinical strategy before they need a stem-cell package.

For severe conditions, a provider willing to review imaging, question candidacy, or recommend an alternative approach can be more valuable than one immediately offering the largest cell dose.

💰 How Much Does Stem Cell Therapy in Thailand Cost for Americans?

Based on current provider pricing and actual treatment proposals reviewed by STEMCIERGE, costs can range from around $10,000 for relatively straightforward orthopedic treatment to more than $100,000 for complex regenerative programs.

There is no useful national “average” because the treatments themselves are too different.

🦵 Around $10,000: simpler orthopedic treatment

STEMCIERGE has reviewed a Thai regenerative treatment proposal of approximately $10,000 for a relatively straightforward orthopedic case.

This is useful as a real-world reference point, but it should not be interpreted as the universal cost of knee or joint stem-cell treatment in Thailand.

🧬 Current MSC package pricing

Current provider pricing reviewed by STEMCIERGE lists early-passage MSC treatment packages at the following levels:

MSC doseTreatment durationPrice30 million1 day$11,75050 million1–3 days$19,500100 million3–5 days$38,000200 million3–5 days$58,000300 million+5–10 days$75,000

One example 100-million-cell program divides the cells between 50 million MSCs administered intravenously and 50 million delivered through local injections, alongside other supportive therapies.

That illustrates an important pricing issue.

A “100-million-cell package” could mean 100 million IV cells, 100 million locally injected cells, a combination of both, or treatment spread across multiple sites.

You need to know what you are actually comparing.

🧠 $50,000+ to $120,000: complex neurological treatment

In the anonymous American spinal cord injury case reviewed through STEMCIERGE:

• one provider proposed approximately $50,000 for epidural spinal cord stimulation, with regenerative treatment adding further cost;
• another proposed approximately $120,000 for a one-month regenerative program, including approximately 60 million stem cells per week alongside other therapies.

These were not two competing versions of the same treatment.

One centered on neuromodulation.

The other centered on an intensive regenerative medicine program.

Comparing the headline prices without that context would be meaningless.

💵 What determines the cost?

Major factors include:

• medical condition;
• complexity of the case;
• cell source;
• manufacturing;
• viable cell dose;
• number of treatment sites;
• IV vs. local administration;
• imaging guidance;
• exosomes or extracellular vesicles;
• diagnostics;
• hospital procedures;
• physiotherapy;
• rehabilitation;
• adjunctive treatments;
• and length of stay.

💡 Price ≠ value

A $40,000 program is not necessarily better than a $15,000 program.

Likewise, 200 million cells are not automatically better than 50 million.

Clinical rationale should come before package size.

🇹🇭🇺🇸 Thailand vs. USA for Stem Cell Therapy: Should Americans Travel Abroad or Stay Home?

Americans should not assume that traveling to Thailand is automatically better than remaining in the United States.

The United States has major advantages in continuity of care.

Your treating physicians, imaging, rehabilitation, emergency services, and follow-up care are all easier to access domestically.

Thailand's potential advantage is different: access to a broader range of commercially available regenerative programs.

📊 Thailand vs. USA at a glance

FactorUnited StatesThailandTravel burdenLow for AmericansLong-haul international travelMain regulatorFDAThai FDAContinuity of careEasierRequires cross-border planningAvailability of many MSC applicationsMore restrictedBroader commercial availabilityFollow-upUsually easierMore difficult after returning homeInsuranceEstablished conventional treatment may be coveredInternational regenerative treatment is usually self-payMulti-day regenerative packagesLess commonly marketed in the same formCommon among some private providersDue diligenceEssentialParticularly importantStrongest reason to chooseFamiliar system and continuityA specific physician or protocol that justifies travel

🏠 When might staying in the USA make more sense?

Staying home deserves serious consideration when:

• established treatment options have stronger evidence;
• you require frequent follow-up;
• international travel creates significant medical risk;
• an appropriate U.S. clinical trial exists;
• complications would be difficult to manage remotely;
• or the overseas proposal does not provide a clear medical advantage.

Conventional treatment does not become inferior simply because it is conventional.

And experimental treatment does not become superior simply because it sounds more advanced.

✈️ When might Thailand make sense?

Thailand becomes more compelling when there is a specific clinical reason to travel.

That may be:

• access to a particular physician;
• a treatment strategy unavailable locally;
• an intensive multidisciplinary program;
• rehabilitation integrated with regenerative treatment;
• or a provider whose expertise appears particularly relevant to the condition.

The right comparison is not:

“Thai stem cells vs. American stem cells.”

It is:

“Treatment option A in the United States vs. treatment option B in Thailand for this specific patient and treatment goal.”

📋 How Should Americans Compare Stem Cell Treatment Proposals?

If you receive multiple quotes, resist the temptation to compare only the headline numbers.

Use this framework:

Don't compare only...Compare instead...PriceEntire treatment protocolTotal cell countViable dose, quality, and routePassage numberManufacturing, testing, and clinical evidenceTestimonialsCondition-specific researchNumber of therapiesMedical rationale for each component“FDA-approved” languageExact regulatory pathwayLuxury inclusionsMedical valuePromised outcomeRealistic benefit, uncertainty, and risks

Ask every provider:

• Why am I considered a candidate?
• What exact cells will I receive?
• Where are they manufactured?
• What is the viable cell dose?
• How are identity and sterility assessed?
• Is endotoxin and mycoplasma testing performed?
• Can I review the Certificate of Analysis?
• How will the cells be administered?
• Who performs the procedure?
• What evidence supports this treatment for my diagnosis?
• What outcomes are realistic?
• What happens if I do not improve?
• What happens if I experience a complication?
• Who follows me once I return to the United States?

Good answers should become more specific as your questions become more specific.

🏥 How Can Americans Evaluate a Stem Cell Clinic in Thailand?

Start with the medical team, not the marketing.

👨‍⚕️ Verify the physician

The Medical Council of Thailand provides an official physician-verification system.⁷

Confirm:

• full physician name;
• active medical license;
• specialty;
• relevant experience;
• who reviews your records;
• and who actually performs the treatment.

A salesperson or patient coordinator can explain logistics.

They should not replace medical assessment.

🏨 Verify the facility

Ask about:

• facility licensing;
• hospital affiliation where applicable;
• emergency arrangements;
• infection-control procedures;
• accreditation;
• and what happens if you require hospital-level care.

🧪 Verify the cell product

Ask for:

• cell source;
• autologous vs. donor-derived status;
• manufacturer;
• passage;
• viable cell count;
• donor screening;
• sterility testing;
• batch or lot number;
• Certificate of Analysis;
• storage conditions;
• and transport procedures.

🚩 Watch for red flags

Be cautious when you encounter:

• guaranteed recovery;
• guaranteed cartilage regeneration;
• “100% safe” claims;
• one identical protocol for many unrelated diseases;
• extreme emphasis on cell count;
• no meaningful physician review;
• refusal to disclose cell source;
• vague manufacturing claims;
• testimonials used as primary proof;
• pressure to pay immediately;
• no complication plan;
• no follow-up strategy.

The ISSCR specifically warns against exaggerated representations of stem-cell interventions and the marketing of unproven treatments.⁴

✈️ What Are the Risks of Traveling Abroad for Stem Cell Therapy?

International medical treatment adds risks that do not exist to the same degree when care is delivered close to home.

These include:

• infection;
• procedural complications;
• delayed adverse events;
• fragmented medical records;
• difficulty contacting the overseas physician;
• problems arranging follow-up;
• unexpected U.S. medical costs after returning;
• and travel-related complications.

The CDC advises medical tourists to investigate clinician qualifications, facility standards, continuity of care, and plans for follow-up before traveling.⁸

Long-haul travel can also matter after certain procedures.

If your treatment affects mobility or includes surgery or another invasive intervention, your return date should be part of the medical plan.

✈️ Your flight home is part of the treatment plan

The right departure date should be based on what was performed, your medical history, mobility, and complication risk, not simply when your hotel reservation ends.

🧳 How Should Americans Prepare Before Traveling to Thailand?

Preparation should begin before you book flights or pay a large deposit.

📁 What medical records should you send?

Depending on the condition, the clinic may need:

• confirmed diagnosis;
• MRI or CT imaging;
• DICOM imaging files;
• radiology reports;
• surgical history;
• medication list;
• allergies;
• relevant laboratory work;
• previous treatment history.

For orthopedic and neurological conditions, the actual imaging can be more useful than the written report alone.

🇺🇸 What should you discuss with your U.S. physician?

Consider discussing:

• whether the proposed treatment conflicts with current care;
• medication changes;
• anticoagulants;
• travel risk;
• contraindications;
• and what follow-up will be necessary.

The CDC recommends planning continuity of care both before and after international medical treatment.⁸

🗂️ What records should you bring home?

Before leaving Thailand, obtain:

• physician notes;
• procedure report;
• diagnosis;
• cell source;
• cell dose;
• route of administration;
• batch information;
• Certificate of Analysis where available;
• medications administered;
• laboratory results;
• discharge instructions;
• rehabilitation plan;
• physician contact information;
• follow-up recommendations.

Your U.S. healthcare team should not have to guess what happened overseas.

🛂 What Are the Entry and Travel Requirements for Americans?

As of 2026, U.S. citizens traveling to Thailand for shorter tourist stays generally benefit from visa-exempt entry, subject to current Thai entry requirements. The U.S. Department of State also advises adequate passport validity and checking Thailand's current pre-arrival requirements before traveling.⁹

Rules can change, so verify them again shortly before departure.

Medical travelers should also consider:

• travel insurance;
• international medical coverage;
• medical evacuation coverage;
• accommodation close to treatment;
• and whether a companion may be needed during recovery.

🌎 Thailand vs. Mexico vs. Colombia: Which Is Better for Americans Seeking Treatment Abroad?

There is no universally best country for regenerative medicine.

Once an American has decided that treatment abroad is worth evaluating, Thailand, Mexico, and Colombia can represent very different tradeoffs.

📊 Thailand vs. Mexico vs. Colombia

FactorThailandMexicoColombiaTravel from the USALongestUsually easiestTypically easier than ThailandMajor advantageExtensive medical-tourism ecosystem and intensive programsProximity and easier repeat visitsAmericas-based alternative with regenerative medicine providersFollow-up logisticsMost difficultOften easiest internationallyMore manageable than Thailand for many AmericansRegulatory due diligenceThai regulatory pathwayMexican regulatory requirements / COFEPRIS contextColombian requirements / INVIMA contextBest reason to chooseSpecific Thai physician or protocolComparable treatment closer to homeStrong provider or protocol fit with easier travel

Mexico's health framework includes provisions governing regenerative medicine and establishments working with cells and related biological materials, while Colombia's INVIMA has addressed advanced therapies including cellular and regenerative approaches.¹⁰ ¹¹

The details still need to be evaluated provider by provider.

🇹🇭 When might Thailand make more sense?

Thailand may make sense when:

• a particular physician has relevant expertise;
• a specific multidisciplinary program is compelling;
• the patient wants treatment and rehabilitation in one location;
• or the treatment strategy appears sufficiently different to justify the travel burden.

🇲🇽 When might Mexico make more sense?

Mexico has an obvious advantage for many Americans: proximity.

That can matter when:

• repeat visits are expected;
• long-haul travel is difficult;
• family members need to accompany the patient;
• or the treatment available is otherwise comparable.

🇨🇴 When might Colombia make more sense?

Colombia can provide another Americas-based alternative, particularly when a provider has relevant expertise, a compelling protocol, and acceptable logistics for the patient.

The same rules apply:

Verify the physician, treatment, product, regulatory pathway, evidence, and follow-up.

🧭 Choose the treatment before the country

A better sequence is:

Diagnosis → Evidence → Treatment strategy → Physician → Cell product → Provider → Country

Not:

Country → Clinic → Stem-cell package

🩺 Who Should Consider Treatment Abroad, and Who Should Be More Cautious?

A person exploring international regenerative medicine is easier to evaluate when they have:

• a reasonably clear diagnosis;
• current medical records;
• appropriate imaging;
• realistic goals;
• medical stability for travel;
• an understanding of uncertainty;
• and a plan for follow-up.

Additional caution may be needed for people with:

• active infections;
• medically unstable conditions;
• significant clotting or bleeding risk;
• unclear diagnoses;
• serious travel limitations;
• inadequate follow-up options;
• or expectations of guaranteed regeneration or recovery.

Sometimes the best recommendation is not to proceed with regenerative treatment.

A provider willing to say that can be more valuable than one willing to treat everyone.

🤝 How STEMCIERGE Helps Americans Compare Treatment Options

STEMCIERGE is not designed to be a directory containing every regenerative medicine clinic willing to accept international patients.

The focus is narrower: helping patients evaluate selected providers and understand whether the proposed treatment actually fits their situation.

That can include:

• reviewing treatment goals;
• helping organize medical records;
• identifying potentially relevant providers;
• facilitating medical evaluations;
• comparing treatment proposals;
• understanding differences between protocols;
• identifying questions worth asking;
• and separating medically relevant information from marketing language.

The anonymous neurological case discussed earlier is a useful example.

The same patient received proposals involving different treatment strategies, different levels of complexity, and very different prices.

That is precisely why simply asking:

“Which stem cell clinic is best?”

is often the wrong starting point.

The better question is:

“What is the most medically reasonable option for my condition, and which provider is best equipped to evaluate it?”

❓ Frequently Asked Questions

Can Americans legally get stem cell therapy in Thailand?

Yes. Americans can travel to Thailand for medical treatment. However, the exact regulatory status of the cell product and its proposed use should be verified under Thailand's applicable regulatory framework rather than assuming every treatment has the same approval status.¹

Is stem cell therapy in Thailand FDA-approved?

U.S. FDA approval does not determine whether treatment may legally be provided in Thailand. Thai law applies in Thailand. However, checking U.S. FDA status can help Americans understand whether the same product or indication has undergone formal U.S. regulatory review.

How much does stem cell therapy cost in Thailand for Americans?

Based on current pricing and proposals reviewed by STEMCIERGE, some simpler orthopedic treatments are around $10,000, while current MSC packages reviewed range from $11,750 to $75,000. Highly complex regenerative programs can exceed $100,000.

Does receiving more stem cells mean better results?

Not necessarily. Total cell dose is only one variable. Cell quality, viability, identity, manufacturing, administration route, patient selection, and evidence for the condition also matter.

Can stem cells regrow knee cartilage?

Current evidence does not establish that stem-cell injections reliably regenerate clinically meaningful normal cartilage or cure knee osteoarthritis. Some studies show improvements in pain and function, but structural regeneration remains uncertain.⁵

Is Thailand better than the USA for stem cell therapy?

Not universally. The United States offers easier continuity of care and a familiar regulatory system. Thailand may provide access to regenerative protocols that are not routinely available in the U.S. The better option depends on the treatment, evidence, physician, cost, risk, and follow-up requirements.

Is Thailand better than Mexico or Colombia?

There is no universally better country. Mexico can be much easier logistically for Americans requiring repeat treatment, while Thailand may make sense when a particular physician or intensive program justifies longer travel. Colombia provides another Americas-based option. Compare actual treatment strategies before choosing a destination.

How long should I stay in Thailand after treatment?

It depends entirely on the procedure. A localized orthopedic injection, multi-day MSC program, and neurosurgical or neurological intervention have very different monitoring and recovery requirements. Your treating physician should determine when long-haul travel is appropriate.

What should I bring back to my U.S. doctor?

Bring your procedure report, diagnosis, cell source and dose, batch information, Certificate of Analysis where available, medications administered, laboratory results, discharge instructions, rehabilitation plan, and contact information for the treating physician.

How do I verify a doctor in Thailand?

The Medical Council of Thailand provides an official physician-verification database. Patients should confirm the treating doctor's active license, specialty, and role in their procedure before treatment.⁷

🎯 Is Thailand Worth Considering for Stem Cell Therapy?

Thailand can be a legitimate option for Americans exploring regenerative medicine, but the country itself should never be the primary reason to undergo treatment.

The strongest reason to travel is not:

• cheaper cells;
• more cells;
• a more luxurious package;
• or a clinic claiming to use the “most advanced” protocol.

It is finding a specific physician, treatment strategy, and product that make enough medical sense to justify leaving the United States.

Before deciding, work through the decision in this order:

Diagnosis → Evidence → Physician → Cell product → Regulatory status → Protocol → Total cost → Follow-up

If Thailand still looks compelling after that level of scrutiny, you have a much stronger reason to make the trip.

Considering regenerative treatment in Thailand?

STEMCIERGE can help you review your situation, compare treatment proposals, and connect with selected providers for further medical evaluation.

Get matched with a vetted clinic.

References

1. Thai Food and Drug Administration. Road to ATMPs: Thai FDA Affirms Thailand Will Not Be Left Behind. 2026.

2. U.S. Food and Drug Administration. FDA Approves First Mesenchymal Stromal Cell Therapy to Treat Steroid-Refractory Acute Graft-versus-Host Disease. 2024.

3. U.S. Food and Drug Administration. Important Patient and Consumer Information About Regenerative Medicine Therapies.

4. International Society for Stem Cell Research. 2025 Guidelines for Stem Cell Research and Clinical Translation and clinical resources.

5. Whittle SL, et al. Stem cell injections for osteoarthritis of the knee. Cochrane Database of Systematic Reviews. 2025.

6. Tangkanjanavelukul P, et al. Cartilage Regeneration Potential in Early Osteoarthritis of the Knee: ADSC Therapy Versus Hyaluronic Acid. International Journal of Molecular Sciences. 2025;26(17):8476.

7. Medical Council of Thailand. Official physician verification database.

8. Centers for Disease Control and Prevention. Medical Tourism. CDC Yellow Book 2026.

9. U.S. Department of State. Thailand International Travel Information.

10. Mexico General Health Law / COFEPRIS. Provisions relevant to regenerative medicine and cell-based healthcare establishments.

11. INVIMA Colombia. Guidance and regulatory materials concerning advanced therapies, regenerative medicine, and cellular therapy.

‍